第60回日本小児血液・がん学会学術集会

講演情報

一般口演

第60回 日本小児血液・がん学会学術集会 » 一般口演

[_OS27] 一般口演27
AML

Oral Session 27 AML

2018年11月16日(金) 13:10 〜 13:50 第2会場 (みやこめっせ B1F 第1展示場A)

座長:多賀 崇(滋賀医科大学小児科), 足立 壯一(京都大学大学院医学研究科人間健康科学系専攻)

[OS27-3-3] RUNX1-RUNX1T1陽性AMLにおいてCD19陰性は予後不良因子となる-JPLSG AML05解析結果-
Negative CD19 expression is associated with inferior relapse free survival in RUNX1-RUNX1T1 positive AML; JPLSG experience from the AML-05 study

Kenichi Sakamoto1,2,3, Norio Shiba4, Takao Deguchi1,5, Nobutaka Kiyokawa6, Yoshiko Hashii7, Akiko Saito3, Daisuke Tomizawa1, Takashi Taga8, Souichi Adachi9, Toshihiko Imamura2 (1.Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan, 2.Department of Pediatrics, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Kyoto, Japan, 3.National Hospital Organization, Clinical Research Center, Nagoya Medical Center, Nagoya, Japan, 4.Department of Pediatrics, Yokohama City University Hospital, Graduate School of Medicine, Yokohama, Japan, 5.Department of Pediatrics, Mie University Graduate School of Medicine, Mie, Japan, 6.Department of Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan, 7.Department of Pediatrics, Osaka University, Osaka, Japan, 8.Department of Pediatrics, Shiga Medical University, Otsu, Shiga, Japan, 9.Department of Human Health Science, Kyoto University, Kyoto, Japan)

抄録パスワード認証
パスワードは抄録集の37ページに記載してあります。

パスワード